Sree Rayalaseema Hi-Strength Hypo enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


812	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
434	434	369	15.1	26.8
13.2	13.2	14.5	0.1	0.2
0.4	0.4	14.4	8.0	11.9
392	—	—	—	—
−434	−434	−355	−7.0	−14.9
₹228.24	—	—	—	—

985	985	948	809	763
0.0%	0.0%	1.5%	1.0%	1.6%
0.00×	—	—	—	—

0.56×	—	—	—	—
4.33×	—	—	—	—
4.71×	—	—	—	—
11.93×	—	—	—	—
698	667	638	866	1,650
90.4	88.5	92.0	111	178
83.2	81.2	84.7	100.0	158
—	39.2	65.2	139	141
32.8	32.8	62.8	119	132
—	32.7	62.6	118	131
—	6.3	2.4	20.0	9.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SRHHYPOLTD₹473.25

Sree Rayalaseema Hi-Strength Hypo Limited

· Chemicals

₹ CrorePeersGEMAROMA DMCC SUDARCOLOR JAYAGROGN KRONOX AMNPLST CHEMFAB PRIMOMcap ₹812 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	812.3
- Cash, Equiv & ST Investments	26.8	15.1	369.0	434.2	434.2
+ Minority Interest	0.2	0.1	14.5	13.2	13.2
+ Total Debt	11.9	8.0	14.4	0.4	0.4
Enterprise Value	—	—	—	—	391.8
Net Debt (memo)	-14.9	-7.0	-354.5	-433.8	-433.8
EV per Share	—	—	—	—	228.24

Total Capital	763.0	808.7	948.4	984.7	984.7
Total Debt/Total Capital	1.56	1.00	1.52	0.04	0.04
Total Debt/EV	—	—	—	—	0.00

EV/Sales	—	—	—	—	0.56
EV/EBITDA	—	—	—	—	4.33
EV/EBIT	—	—	—	—	4.71
EV/Free Cash Flow	—	—	—	—	11.93
Reference Items — Trailing FY Values
Sales	1,650.1	866.0	637.8	667.0	697.6
EBITDA	177.7	110.6	92.0	88.5	90.4
EBIT	158.3	100.0	84.7	81.2	83.2
Operating Cash Flow	141.4	138.6	65.2	39.2	—
Free Cash Flow	131.5	118.6	62.8	32.8	32.8
FCFF (free cash flow to the firm)	131.2	117.6	62.6	32.7	—
Capital Expenditure	9.9	20.0	2.4	6.3	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.